Milestones
EC & UK MHRA Marketing Authorization for Yselty® (linzagolix) in Q2:22
CHMP confirmation of positive opinion (Q2:22)
NDA PDUFA action Q3:22
Clinical Trials
Recruitment Completed
Commercial Rights
ObsEva holds U.S. and Canadian rights
Kissei holds Asian rights
Exclusive worldwide rights outside of the U.S., Canada, and Asia licensed to Theramex